Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
Get Alerts JNJ Hot Sheet
Join SI Premium – FREE
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 4.2% increase in the quarterly dividend, from $1.19 per share to $1.24 per share, marking the 62nd year of consecutive increases.
At the new rate, the indicated dividend on an annual basis is $4.96 per share compared to the previous rate of $4.76 per share. The next quarterly dividend is payable on June 4, 2024 to shareholders of record at the close of business on May 21, 2024. The ex-dividend date is May 20, 2024.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240416660427/en/
Media contact:
Tesia Williams
[email protected]
Investor contact:
Jessica Moore
[email protected]
Source: Johnson & Johnson
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xerox Announces Exchange Transaction to Extend Portion of 2028 Debt Maturities and Reduce Overall Debt
- Netradyne Strengthens Executive Leadership with New Chief People and Chief Marketing Officers
- D.R. Horton, Inc., America’s Builder, Reports Fourth Quarter and Fiscal 2026 Earnings and Increases Quarterly Dividend to $0.50 Per Share
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share